In experimental models of metabolic syndrome and myocardial ischemia, FF treatment has been shown to regulate both the classical (ACE/Ang II/AT1R) and non-classical (ACE2/Ang-(1–7)/AT2R/MAS) RAS axes, primarily in cardiac tissue [34]. This evidence concerns the gene AGTR1 and metabolic syndrome.